Calendar ASLAN Pharmaceuticals Limited Taipei Exchange
Equities
6497
KYG054241099
Chart calendar ASLAN Pharmaceuticals Limited
Upcoming events on ASLAN Pharmaceuticals Limited
Past events on ASLAN Pharmaceuticals Limited
2024-05-20 12:15 pm | American Thoracic Society International Conference - Poster No 13753 |
2024-05-09 07:00 am | Q1 2024 Earnings Release |
2024-05-07 08:00 am | Investor Meeting - Key Opinion Leader |
2024-04-12 08:00 am | Q4 2023 Earnings Release |
2024-03-28 08:00 am | H.C. Wainwright Autoimmune and Inflammatory Disease Conference |
2024-01-09 | LifeSci Partners Corporate Access Event |
2024-01-07 | Biotech Showcase |
2024-01-06 | Dermatology Summit |
2023-11-29 11:30 am | Piper Sandler Healthcare Conference |
2023-10-30 | Dermatology Drug Development Summit |
2023-10-27 08:00 am | Q3 2023 Earnings Release |
2023-10-24 11:00 am | Investor Meeting - Key Opinion Leader |
2023-09-11 10:30 am | H.C. Wainwright Global Investment Conference |
2023-08-11 07:00 am | Q2 2023 Earnings Release |
2023-07-06 08:30 am | TREK-AD Phase 2b Trial Results Call |
2023-06-08 04:30 pm | Jefferies Global Healthcare Conference |
2023-05-13 12:15 am | International Societies for Investigative Dermatology Meeting - Abstract Number : LB1751 |
2023-05-09 | International Societies for Investigative Dermatology Meeting - Abstract Number : LB1777 |
2023-05-09 | International Societies for Investigative Dermatology Meeting - Abstract Number : 657 |
2023-05-09 | International Societies for Investigative Dermatology Meeting - Abstract Number : 1594 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million TWD | Released Forecast Spread | 90,7 91,4 -0.81% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 387 379 2.21% | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million TWD | Released Forecast Spread | -1 378 -674 -104.55% | -463 -402 -15.28% | -971 -889 -9.19% | -1 451 -1 404 -3.35% | -1 411 -1 321 -6.77% | -2 262 |
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -1 410 -682 -106.67% | -477 -427 -11.78% | -906 -850 -6.61% | -1 554 -1 506 -3.23% | -1 422 -1 347 -5.55% | -2 356 |
Net income Million TWD | Released Forecast Spread | -1 421 -694 -104.65% | -455 -423 -7.7% | -898 -857 -4.76% | -1 557 -1 506 -3.39% | -1 427 -1 350 -5.64% | -2 356 |
EPS USD | Released Forecast Spread | -58,0 -29,6 -95.95% | -16,0 -11,5 -39.53% | -19,2 -19,1 -0.7% | -29,4 -28,2 -4.25% | -21,5 -20,9 -3.07% | -26,7 |
Announcement Date | 18/03/20 | 22/04/21 | 25/03/22 | 24/03/23 | 12/04/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million TWD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 381 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million TWD | Released Forecast Spread | -319 -258 -23.66% | -349 -291 -19.94% | -369 -372 0.85% | -330 -394 16.46% | -406 -349 -16.18% | -557 -398 -39.89% | -75,2 -479 84.29% | -338 -460 26.43% | -414 -346 -19.63% | -301 -371 18.73% | -308 | -324 | -1 329 | -381 |
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -262 -268 2.24% | -380 -310 -22.47% | -391 -403 3.07% | -349 -425 17.76% | -436 -378 -15.33% | -588 -423 -39.15% | -58,1 -527 88.97% | -314 -494 36.35% | -435 -381 -14.03% | -322 -397 19.06% | -331 | -348 | -1 355 | -408 |
Net income Million TWD | Released Forecast Spread | -262 -277 5.41% | -380 -310 -22.47% | -391 -419 6.77% | -350 -425 17.69% | -439 -378 -15.97% | -588 -423 -39.2% | -59,9 -496 87.91% | -315 -494 36.16% | -436 -381 -14.37% | -322 -397 19.06% | -331 | -348 | -1 355 | -408 |
EPS USD | Released Forecast Spread | -6,40 -5,73 -11.63% | -7,60 -7,20 -5.56% | -7,60 -4,80 -58.33% | -6,40 -7,60 15.79% | -8,32 -7,12 -16.85% | -10,3 -3,48 -196.55% | -0,88 -6,40 86.25% | -4,48 -6,16 27.27% | -6,32 -5,20 -21.54% | -4,24 -4,88 13.11% | -3,60 | -3,76 | -14,6 | -4,40 |
Announcement Date | 25/03/22 | 27/04/22 | 12/08/22 | 28/10/22 | 24/03/23 | 28/04/23 | 11/08/23 | 27/10/23 | 12/04/24 | 09/05/24 | - | - | - | - |
Past sector events for ASLAN Pharmaceuticals Limited
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |